Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SUHAIL H KHADRA

NPI
1487603239
CMS profile
66653
Location
MUNSTER, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$994.78

34 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $702.70 33
Travel and Lodging $292.08 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SUHAIL H KHADRA

NPI 1487603239 · CMS profile ID 66653

MUNSTER, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1487603239?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SUHAIL H KHADRA, NPI 1487603239, CMS profile ID 66653. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1487603239?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). SUHAIL H KHADRA, NPI 1487603239, CMS profile ID 66653. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1487603239?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
SUHAIL H KHADRA, NPI 1487603239, CMS profile ID 66653, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1487603239?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

34 matching records · $994.78 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 34 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–34 of 34.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
BIOTRONIK NRO, Inc. $21.1611/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051960227 CMS
Novartis Pharmaceuticals Corporation $12.7711/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999625 CMS
Novartis Pharmaceuticals Corporation $17.8210/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999621 CMS
Novartis Pharmaceuticals Corporation $17.4509/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999617 CMS
Novo Nordisk Inc $20.4409/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002066515 CMS
Lexicon Pharmaceuticals, Inc. $15.1009/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040731893 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $22.7008/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 983863289 CMS
Novartis Pharmaceuticals Corporation $14.4808/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999613 CMS
Novartis Pharmaceuticals Corporation $12.8908/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999605 CMS
Novartis Pharmaceuticals Corporation $19.0708/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999609 CMS
Novartis Pharmaceuticals Corporation $12.2708/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999593 CMS
Novartis Pharmaceuticals Corporation $18.8207/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999597 CMS
Novartis Pharmaceuticals Corporation $0.6407/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999601 CMS
Novartis Pharmaceuticals Corporation $12.0807/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999589 CMS
Novartis Pharmaceuticals Corporation $13.5507/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999585 CMS
Novartis Pharmaceuticals Corporation $11.9707/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999581 CMS
Novartis Pharmaceuticals Corporation $12.4706/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999577 CMS
Janssen Research & Development, LLC $25.0005/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061054265 CMS
Janssen Research & Development, LLC $125.0005/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061054269 CMS
Janssen Research & Development, LLC $292.0805/17/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061054275 CMS
Janssen Research & Development, LLC $40.0005/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061054281 CMS
Janssen Research & Development, LLC $20.0005/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061054287 CMS
Janssen Research & Development, LLC $60.0005/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061054293 CMS
Janssen Research & Development, LLC $20.0005/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061054299 CMS
Novartis Pharmaceuticals Corporation $14.0405/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999573 CMS
Novartis Pharmaceuticals Corporation $19.7804/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999569 CMS
Cardiovascular Systems Inc. $13.6304/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1027187971 CMS
Novartis Pharmaceuticals Corporation $18.4004/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999565 CMS
Novartis Pharmaceuticals Corporation $11.2902/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999561 CMS
Novartis Pharmaceuticals Corporation $17.3502/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999557 CMS
Merck Sharp & Dohme LLC $11.1502/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048437587 CMS
Novartis Pharmaceuticals Corporation $17.6801/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999553 CMS
Kestra Medical Technology Services, Inc. $26.8401/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 976375769 CMS
Novartis Pharmaceuticals Corporation $6.8601/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991999549 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $540.50 20
PY2020 $292.38 14
PY2021 $543.76 36
PY2022 $794.26 44
PY2023 $994.78 34
PY2024 $913.91 39
PY2025 $621.54 29

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $1,061,757.66 207
PY2024 Principal investigator $654,195.55 69
PY2023 Principal investigator $594,110.73 53
PY2022 Principal investigator $288,215.55 37

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

37 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $7,308.04 12/31/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the efficacy and safety of AZD4831 administered for up to 48 Weeks in participants with heart failure with left ventricular ejection fractio No dispute reported 06/30/2026 914589515
Principal investigator 1 Merck Sharp & Dohme LLC $73,990.22 12/31/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH
A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction No dispute reported 06/30/2026 940400013
Principal investigator 1 Merck Sharp & Dohme LLC $6,243.16 12/31/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH
A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction No dispute reported 06/30/2026 940400015
Principal investigator 1 Merck Sharp & Dohme LLC $1,921.58 12/31/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH
A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction No dispute reported 06/30/2026 940400147
Principal investigator 1 Merck Sharp & Dohme LLC $1,176.40 12/31/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH
A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction No dispute reported 06/30/2026 940400149
Principal investigator 1 Novo Nordisk AS $1,826.82 12/21/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897006821
Principal investigator 1 Novo Nordisk AS $1,703.25 12/21/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4773 No dispute reported 06/30/2026 897106331
Principal investigator 1 Novo Nordisk AS $1,917.00 12/21/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4665 No dispute reported 06/30/2026 897308999
Principal investigator 1 PFIZER INC. $9,500.00 12/07/2022 Non-covered Recipient Entity
Chicago Medical Research LLC
A PHASE 2 DOUBLEBLIND RANDOMIZED PLACEBOCONTROLLED 4ARM STUDY TO INVESTIGATE SYMPTOMS FUNCTION HEALTHRELATED QUALITY OF LIFE AND SAFETY WITH REPEATED SUBCUTANEOUS ADMINISTRATION OF PONSEGROMAB VERSUS PLACEBO IN ADULT PARTICIPANTS WITH HEART FAILURE No dispute reported 06/30/2026 949773277
Principal investigator 1 Novo Nordisk AS $3,102.30 12/02/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896973457
Principal investigator 1 Novo Nordisk AS $399.37 11/30/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4773 No dispute reported 06/30/2026 897242801
Principal investigator 1 Novo Nordisk AS $1,189.08 10/21/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896860669
Principal investigator 1 Novo Nordisk AS $2,435.62 10/21/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4773 No dispute reported 06/30/2026 897106327
Principal investigator 1 Novo Nordisk AS $1,687.50 10/21/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4665 No dispute reported 06/30/2026 897297439
Principal investigator 1 Novo Nordisk AS $5,043.06 09/30/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896980733
Principal investigator 1 Novo Nordisk AS $7,234.87 09/30/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4773 No dispute reported 06/30/2026 897150069
Principal investigator 1 Novo Nordisk AS $675.00 08/26/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896980729
Principal investigator 1 Novo Nordisk AS $2,371.14 08/26/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896989171
Principal investigator 1 Novo Nordisk AS $2,741.62 08/22/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4773 No dispute reported 06/30/2026 897175371
Principal investigator 1 Novo Nordisk AS $2,973.37 08/22/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4665 No dispute reported 06/30/2026 897297435
Principal investigator 1 Novo Nordisk AS $4,228.20 07/27/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897015865
Principal investigator 1 Novo Nordisk AS $5,099.62 07/27/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4773 No dispute reported 06/30/2026 897217241
Principal investigator 1 Novo Nordisk AS $1,107.00 07/27/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4665 No dispute reported 06/30/2026 897274123
Principal investigator 1 Novo Nordisk AS $5,493.06 06/29/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896930401
Principal investigator 1 Novo Nordisk AS $18,428.17 06/29/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4665 No dispute reported 06/30/2026 897304405
Principal investigator 1 AstraZeneca Pharmaceuticals LP $70,753.37 06/24/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
This is a randomised double blind placebo controlled multi center sequential phase 2b and Phase 3 study to evaluate the efficacy and safety of AZD4831 administered for up to 48 Weeks in participants with heart failure with left ventricular ejection fractio No dispute reported 06/30/2026 914602051
Principal investigator 1 Novo Nordisk AS $10,083.37 05/27/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4773 No dispute reported 06/30/2026 897175375
Principal investigator 1 Novo Nordisk AS $450.00 05/25/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 896922655
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $18,135.00 05/09/2022 Non-covered Recipient Entity
Chicago Medical Research, Llc
A Study of Mavacamten in Participants With HFpEF and Chronic Elevation of cTnI and/or NT-proBNP (EMBARK-HFpEF) No dispute reported 06/30/2026 933187359
Principal investigator 1 Novo Nordisk AS $5,517.72 04/29/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897015869
Principal investigator 1 Novo Nordisk AS $1,648.12 04/29/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4665 No dispute reported 06/30/2026 897190167
Principal investigator 1 Novo Nordisk AS $3,498.75 04/29/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4773 No dispute reported 06/30/2026 897261929
Principal investigator 1 Novo Nordisk AS $2,507.76 02/25/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897141455
Principal investigator 1 Novo Nordisk AS $844.87 02/25/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4773 No dispute reported 06/30/2026 897150073
Principal investigator 1 Novo Nordisk AS $2,142.00 02/23/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4665 No dispute reported 06/30/2026 897304409
Principal investigator 1 Novo Nordisk AS $288.18 02/18/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897141459
Principal investigator 1 Novo Nordisk AS $2,550.96 02/09/2022 Non-covered Recipient Entity
CHICAGO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 897097447